Enliven Therapeutics
ELVN
#4346
Rank
โ‚ฌ2.07 B
Marketcap
34,73ย โ‚ฌ
Share price
12.87%
Change (1 day)
75.71%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2024: -โ‚ฌ90.53 Million

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ90.53 Million a decrease over its 2023 earnings that were of -โ‚ฌ72.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024-โ‚ฌ90.53 Million25.17%
2023-โ‚ฌ72.32 Million115.33%
2022-โ‚ฌ33.59 Million